RadNet EBITDA 2012-2026 | RDNT

RadNet annual and quarterly EBITDA history from 2012 to 2026. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
  • RadNet EBITDA for the quarter ending June 30, 2026 was $0.102B, a 21.26% increase year-over-year.
  • RadNet EBITDA for the twelve months ending June 30, 2026 was $0.308B, a 11.74% increase year-over-year.
  • RadNet 2025 annual EBITDA was $0.279B, a 11.47% decline from 2024.
  • RadNet 2024 annual EBITDA was $0.315B, a 7.02% increase from 2023.
  • RadNet 2023 annual EBITDA was $0.295B, a 24.12% increase from 2022.
Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts
RadNet Annual EBITDA
(Millions of US $)
2025 $279
2024 $315
2023 $295
2022 $237
2021 $260
2020 $198
2019 $222
2018 $108
2017 $120
2016 $110
2015 $105
2014 $118
2013 $107
2012 $111
2011 $115
RadNet Quarterly EBITDA
(Millions of US $)
2026-06-30 $102
2026-03-31 $38
2025-12-31 $85
2025-09-30 $83
2025-06-30 $84
2025-03-31 $28
2024-12-31 $77
2024-09-30 $86
2024-06-30 $92
2024-03-31 $60
2023-12-31 $72
2023-09-30 $93
2023-06-30 $74
2023-03-31 $55
2022-12-31 $71
2022-09-30 $55
2022-06-30 $67
2022-03-31 $44
2021-12-31 $50
2021-09-30 $78
2021-06-30 $72
2021-03-31 $60
2020-12-31 $63
2020-09-30 $64
2020-06-30 $40
2020-03-31 $31
2019-12-31 $62
2019-09-30 $55
2019-06-30 $60
2019-03-31 $44
2018-12-31 $20
2018-09-30 $35
2018-06-30 $35
2018-03-31 $18
2017-12-31 $36
2017-09-30 $29
2017-06-30 $32
2017-03-31 $24
2016-12-31 $33
2016-09-30 $31
2016-06-30 $25
2016-03-31 $21
2015-12-31 $29
2015-09-30 $33
2015-06-30 $29
2015-03-31 $15
2014-12-31 $30
2014-09-30 $31
2014-06-30 $34
2014-03-31 $23
2013-12-31 $27
2013-09-30 $26
2013-06-30 $30
2013-03-31 $24
2012-12-31 $23
2012-09-30 $29
2012-06-30 $32
2012-03-31 $28
2011-12-31 $32
2011-09-30 $27
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $6.069B $2.040B
RadNet, Inc., is a national market leader providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers. RadNet offers to its patients and referring physicians the full spectrum of diagnostic imaging exams, including PET/CT, MRI, CT, Nuclear Medicine, Mammography, Ultrasound and X-ray, as well as numerous other procedures. RadNet utilizes best of breed technology to appropriately serve the medical communities in which it operates.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $29.581B 13.26
Quest Diagnostics (DGX) United States $27.271B 23.22
DaVita (DVA) United States $12.179B 14.91
Encompass Health (EHC) United States $12.036B 20.89
Elanco Animal Health (ELAN) United States $11.491B 21.70
Chemed (CHE) United States $6.620B 23.60
LifeStance Health (LFST) United States $4.991B 100.46
Option Care Health (OPCH) United States $3.523B 14.89
Aveanna Healthcare Holdings (AVAH) United States $3.123B 21.68
Addus HomeCare (ADUS) United States $2.164B 19.57
Astrana Health (ASTH) United States $2.138B 22.69
Pennant (PNTG) United States $1.396B 36.34
U.S Physical Therapy (USPH) United States $1.220B 32.19
Daxor (DXR) United States $0.065B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.024B 0.00
Psychemedics (PMD) United States $0.000B 0.00